The TAVR procedure has revolutionized a challenging task in heart care: fixing stiff valves. And it has made the process much easier for patients, getting them back to an active life faster.

The heart’s four valves – the mitral, aortic, pulmonary, and tricuspid – open and close to move blood around the body. If a valve becomes damaged or stretched, it can also become leaky. This ...

Total sales grew 2.9% YoY to $5.4 billion (+0.3% vs. consensus) aided by Transcatheter Aortic Valve Replacement segment grew 2.8% YoY to $3.5 billion, Surgical Structural Heart division grew ...

COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced successful results in an additional 5 patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the ...

DEAR DR. ROACH: I’ve had a leaky aortic valve for approximately six years. I recently had an echocardiogram using Doppler. The last test I received was three years ago, which came back with a ...

Swedish offers new research options for patients with aortic, mitral and tricuspid valve disease. Visit the Swedish website to learn more about the Swedish Structural Heart and Valve Program.

The device will be used to treat patients with symptomatic severe aortic stenosis who are at high or extreme risk for open-heart surgery. This week, a structural heart team composed of interventional ...

At baseline, the mechanical valve group tended to be younger (55.7 vs 65.2) and had less aortic stenois (82.4% vs 89.5%), but more moderate and severe aortic regurgitation (39.0% vs 30.5%).

In a fitting move for the maker of heart-valve-opening technology, California-based startup JenaValve has taken another step toward opening up the device’s pathway to the U.S. commercial market.